Skip to main content
Top
Published in: Breast Cancer 2/2020

01-03-2020 | Adjustment Disorder | Original Article

Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection

Authors: Yoshiteru Akezaki, Eiji Nakata, Masato Kikuuchi, Ritsuko Tominaga, Hideaki Kurokawa, Makiko Hamada, Kenjiro Aogi, Shozo Ohsumi, Shinsuke Sugihara

Published in: Breast Cancer | Issue 2/2020

Login to get access

Abstract

Background

The purpose of this study was to investigate the factors related to early postoperative psychological conditions in breast cancer patients with axillary lymph node dissection 3 months after the surgery.

Methods

The subjects of this study were 200 consecutive patients who underwent axillary lymph node dissection for breast cancer at our hospital. Age, body mass index, surgical side, work, marriage, presence of children, presence of co-resident household members, resection of the pectoralis minor muscle, preoperative chemotherapy, postoperative chemotherapy, postoperative hormonal therapy, postoperative radiotherapy, shoulder range of motion, upper limb function (Disabilities of the Arm, Shoulder and Hand; DASH), and psychological conditions were evaluated. In this study, a Distress and Impact Thermometer was used to classify patients with adjustment disorders, depression, or major depression and suicidal ideation into a group with psychological problems and the remaining patients into a group with no psychological problems.

Results

Logistic regression analysis showed that only DASH was statistically significantly associated with psychological conditions (p < 0.05). Using receiver operating characteristic curve analysis, a DASH score of 18 or greater was found to be very specific for predicting psychological conditions.

Conclusions

The observation that somatic symptoms and disability of upper limb function are related to psychological conditions may indicate the importance of postoperative rehabilitation in breast cancer patients with axillary lymph node dissection.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71–96.CrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71–96.CrossRef
2.
go back to reference Snell L, McCarthy C, Klassen A, Cano S, Rubin L, Hurley K, et al. Clarifying the expectations of patients undergoing implant breast reconstruction: a qualitative study. Plast Reconstr Surg. 2010;126:1825–30.CrossRef Snell L, McCarthy C, Klassen A, Cano S, Rubin L, Hurley K, et al. Clarifying the expectations of patients undergoing implant breast reconstruction: a qualitative study. Plast Reconstr Surg. 2010;126:1825–30.CrossRef
3.
go back to reference Derogatis LR. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–7.CrossRef Derogatis LR. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–7.CrossRef
4.
go back to reference Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med. 2002;16:81–97.CrossRef Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med. 2002;16:81–97.CrossRef
5.
go back to reference Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer. 1996;78:1131–7.CrossRef Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer. 1996;78:1131–7.CrossRef
6.
go back to reference Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, et al. Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat. 2000;61:131–7.CrossRef Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, et al. Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat. 2000;61:131–7.CrossRef
7.
go back to reference Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer. 2001;92:2609–22.CrossRef Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer. 2001;92:2609–22.CrossRef
8.
go back to reference Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19–28.CrossRef Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19–28.CrossRef
9.
go back to reference Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer patients. Br J Psychiatry. 1990;156:79–83.CrossRef Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer patients. Br J Psychiatry. 1990;156:79–83.CrossRef
10.
go back to reference Visser MR, Smets EM. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 1998;6:101–8.CrossRef Visser MR, Smets EM. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 1998;6:101–8.CrossRef
11.
go back to reference DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.CrossRef DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.CrossRef
12.
go back to reference Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI. The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res. 2007;9:R44.CrossRef Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI. The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res. 2007;9:R44.CrossRef
13.
go back to reference Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60:39–47.CrossRef Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60:39–47.CrossRef
14.
go back to reference Morrill EF, Brewer NT, O’Neill SC, Lillie SE, Dees EC, Carey LA, et al. The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology. 2008;17:948–53.CrossRef Morrill EF, Brewer NT, O’Neill SC, Lillie SE, Dees EC, Carey LA, et al. The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology. 2008;17:948–53.CrossRef
15.
go back to reference Ollonen P, Lehtonen J, Eskelinen M. Anxiety, depression, and the history of psychiatric symptoms in patients with breast disease: a prospective case-control study in Kuopio Finland. Anticancer Res. 2005;25:2527–33.PubMed Ollonen P, Lehtonen J, Eskelinen M. Anxiety, depression, and the history of psychiatric symptoms in patients with breast disease: a prospective case-control study in Kuopio Finland. Anticancer Res. 2005;25:2527–33.PubMed
16.
go back to reference Smith EM, Gomm SA, Dickens CM. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med. 2003;17:509–13.CrossRef Smith EM, Gomm SA, Dickens CM. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med. 2003;17:509–13.CrossRef
17.
go back to reference Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004;38:320–6.CrossRef Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004;38:320–6.CrossRef
18.
go back to reference Chochinov HM, Wilson KG, Enns M, Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry. 1997;154:674–6.CrossRef Chochinov HM, Wilson KG, Enns M, Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry. 1997;154:674–6.CrossRef
19.
go back to reference Akizuki N, Akechi T, Nakanishi T, Yoshikawa E, Okamura M, Nakano T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer. 2003;97:2605–13.CrossRef Akizuki N, Akechi T, Nakanishi T, Yoshikawa E, Okamura M, Nakano T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer. 2003;97:2605–13.CrossRef
20.
go back to reference Baken DM, Woolley C. Validation of the distress thermometer, impact thermometer and combinations of these in screening for distress. Psychooncology. 2011;20:609–14.CrossRef Baken DM, Woolley C. Validation of the distress thermometer, impact thermometer and combinations of these in screening for distress. Psychooncology. 2011;20:609–14.CrossRef
21.
go back to reference Patrick-Miller LJ, Broccoli TL, Much JK, Levine E. Validation of the Distress Thermometer: a single item screen to detect clinically significant psychological distress in ambulatory oncology patients (Meeting Abstracts). J Clin Oncol. 2004;22:6024.CrossRef Patrick-Miller LJ, Broccoli TL, Much JK, Levine E. Validation of the Distress Thermometer: a single item screen to detect clinically significant psychological distress in ambulatory oncology patients (Meeting Abstracts). J Clin Oncol. 2004;22:6024.CrossRef
22.
go back to reference Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y. Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manag. 2005;29:91–9.CrossRef Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y. Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manag. 2005;29:91–9.CrossRef
23.
go back to reference Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29:602–8.CrossRef Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29:602–8.CrossRef
24.
go back to reference Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety and adjustment disorder in oncological, haematological and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRef Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety and adjustment disorder in oncological, haematological and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRef
25.
go back to reference Beaton DE, Davis AM, Hudak P, McConnell S. The DASH (disabilities of the arm, shoulder and hand) outcome measure: what do we know about it now? Br J Hand Ther. 2001;6:109–18.CrossRef Beaton DE, Davis AM, Hudak P, McConnell S. The DASH (disabilities of the arm, shoulder and hand) outcome measure: what do we know about it now? Br J Hand Ther. 2001;6:109–18.CrossRef
26.
go back to reference Bruce J, Williamson E, Lait C, Richmond H, Betteley L, Lall R, et al. Randomised controlled trial of exercise to prevent shoulder problems in women undergoing breast cancer treatment: study protocol for the prevention of shoulder problems trial (UK PROSPER). BMJ Open. 2018;8:e019078.CrossRef Bruce J, Williamson E, Lait C, Richmond H, Betteley L, Lall R, et al. Randomised controlled trial of exercise to prevent shoulder problems in women undergoing breast cancer treatment: study protocol for the prevention of shoulder problems trial (UK PROSPER). BMJ Open. 2018;8:e019078.CrossRef
27.
go back to reference Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, et al. Time course of upper limb function and return-to-work post-radiotherapy in young adults with breast cancer: a pilot randomized control trial on effects of targeted exercise program. J Cancer Surviv. 2017;11:791–9.CrossRef Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, et al. Time course of upper limb function and return-to-work post-radiotherapy in young adults with breast cancer: a pilot randomized control trial on effects of targeted exercise program. J Cancer Surviv. 2017;11:791–9.CrossRef
28.
go back to reference Şener HÖ, Malkoç M, Ergin G, Karadibak D, Yavuzşen T. Effects of clinical pilates exercises on patients developing lymphedema after breast cancer treatment: a randomized clinical trial. J Breast Health. 2017;13:16–22.CrossRef Şener HÖ, Malkoç M, Ergin G, Karadibak D, Yavuzşen T. Effects of clinical pilates exercises on patients developing lymphedema after breast cancer treatment: a randomized clinical trial. J Breast Health. 2017;13:16–22.CrossRef
29.
go back to reference Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33:1104–11.CrossRef Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33:1104–11.CrossRef
30.
go back to reference Crosbie J, Kilbreath SL, Dylke E, Refshauge KM, Nicholson LL, Beith JM, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90:679–92.CrossRef Crosbie J, Kilbreath SL, Dylke E, Refshauge KM, Nicholson LL, Beith JM, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90:679–92.CrossRef
31.
go back to reference Little CA, Williams SE, Puzanovova M, Rudzinski ER, Walker LS. Multiple somatic symptoms linked to positive screen for depression in pediatric patients with chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2007;44:58–62.CrossRef Little CA, Williams SE, Puzanovova M, Rudzinski ER, Walker LS. Multiple somatic symptoms linked to positive screen for depression in pediatric patients with chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2007;44:58–62.CrossRef
32.
go back to reference Zwaigenbaum L, Szatmari P, Boyle MH, Offord DR. Highly somatizing young adolescents and the risk of depression. Pediatrics. 1999;103:1203–9.CrossRef Zwaigenbaum L, Szatmari P, Boyle MH, Offord DR. Highly somatizing young adolescents and the risk of depression. Pediatrics. 1999;103:1203–9.CrossRef
33.
go back to reference Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2000;62:141–50.CrossRef Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2000;62:141–50.CrossRef
34.
go back to reference Cicero V, Lo Coco G, Gullo S, Lo VG. The role of attachment dimensions and perceived social support in predicting adjustment to cancer. Psychooncology. 2009;18:1045–52.CrossRef Cicero V, Lo Coco G, Gullo S, Lo VG. The role of attachment dimensions and perceived social support in predicting adjustment to cancer. Psychooncology. 2009;18:1045–52.CrossRef
35.
go back to reference Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol. 2009;48:1128–36.CrossRef Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol. 2009;48:1128–36.CrossRef
36.
go back to reference Rizalar S, Ozbas A, Akyolcu N, Gungor B. Effect of perceived social support on psychosocial adjustment of Turkish patients with breast cancer. Asian Pac J Cancer Prev. 2014;15:3429–34.CrossRef Rizalar S, Ozbas A, Akyolcu N, Gungor B. Effect of perceived social support on psychosocial adjustment of Turkish patients with breast cancer. Asian Pac J Cancer Prev. 2014;15:3429–34.CrossRef
37.
go back to reference Özpolat AGY, Ayaz T, Konağ Ö, Özkan A. Attachment style and perceived social support as predictors of biopsychosocial adjustment to cancer. Turk J Med Sci. 2014;44:24–30.CrossRef Özpolat AGY, Ayaz T, Konağ Ö, Özkan A. Attachment style and perceived social support as predictors of biopsychosocial adjustment to cancer. Turk J Med Sci. 2014;44:24–30.CrossRef
Metadata
Title
Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection
Authors
Yoshiteru Akezaki
Eiji Nakata
Masato Kikuuchi
Ritsuko Tominaga
Hideaki Kurokawa
Makiko Hamada
Kenjiro Aogi
Shozo Ohsumi
Shinsuke Sugihara
Publication date
01-03-2020
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2020
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-019-01020-y

Other articles of this Issue 2/2020

Breast Cancer 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine